These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 6692765)

  • 1. [Importance of prolactin determination in metastatic breast cancer].
    Wander HE; Holtkamp W; Nagel GA
    Dtsch Med Wochenschr; 1984 Jan; 109(2):62-3. PubMed ID: 6692765
    [No Abstract]   [Full Text] [Related]  

  • 2. Importance of serum prolactin determination in metastatic breast cancer patients.
    Mujagić Z; Mujagić H
    Croat Med J; 2004 Apr; 45(2):176-80. PubMed ID: 15103755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma-prolactin concentrations in breast cancer at various stages, in mastopathy and other malignant tumors].
    Holtkamp W; von Heyden D; Rauschecker H; Nagel GA
    Schweiz Med Wochenschr; 1983 Oct; 113(41):1513-20. PubMed ID: 6635641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum leptin, prolactin and vascular endothelial growth factor (VEGF) levels in patients with breast cancer.
    Coskun U; Günel N; Toruner FB; Sancak B; Onuk E; Bayram O; Cengiz O; Yilmaz E; Elbeg S; Ozkan S
    Neoplasma; 2003; 50(1):41-6. PubMed ID: 12687277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlations between PRL and 17-beta-E in human breast cancer].
    Larrad Jiménez A; Ruiz-Tartas A; Zapatero Gaviria J; López Lazareno N
    Rev Esp Oncol; 1984; 31(2):279-87. PubMed ID: 6549590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhythmic fluctuations of CEA serum levels in breast cancer patients.
    Jäger W; Diedrich M; Sauerbrei W; Wildt L
    Anticancer Res; 1987; 7(4B):711-5. PubMed ID: 3674759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlations between prolactin and somatotropic hormone in human breast cancer].
    Larrad Jiménez A; Caballero Asensi A; Estévez Molina M
    Rev Esp Oncol; 1980; 27(1):29-52. PubMed ID: 7209107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prolactin. Radioimmunoassay in female breast cancers and benign mastopathies].
    Gorins A; Netter A
    Nouv Presse Med; 1974 Jan; 3(2):73-5. PubMed ID: 4815434
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prolactin and human cancer of the breast. I. Levels of correlation].
    Cueto Ladrón de Guevara J; Villalba Moreno J; García Puche JL; Pedraza V
    Rev Esp Oncol; 1985; 32(3):439-58. PubMed ID: 3870536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating tumor markers in breast cancer.
    Tondini C; Hayes DF; Kufe DW
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):653-74. PubMed ID: 2691493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin as a local growth promoter in patients with breast cancer: GCRI experience.
    Bhatavdekar JM; Patel DD; Shah NG; Vora HH; Suthar TP; Ghosh N; Chikhlikar PR; Trivedi TI
    Eur J Surg Oncol; 2000 Sep; 26(6):540-7. PubMed ID: 11034803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Radioimmunologic analysis of ferritin, carcinoembryonic antigen and prolactin for evaluating the prognosis and effectiveness of treating breast cancer].
    Skliar SIu; Chebotareva ED; Ganul VL; Korolev VI
    Med Radiol (Mosk); 1987 Oct; 32(10):32-6. PubMed ID: 3657434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prolactin and cancer of the breast. II. Prediction of the response to hormone treatment. The Minton test].
    Cueto Ladrón de Guevara J; García Puche JL; Pedraza V
    Rev Esp Oncol; 1985; 32(3):459-70. PubMed ID: 3870537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.
    Tworoger SS; Eliassen AH; Sluss P; Hankinson SE
    J Clin Oncol; 2007 Apr; 25(12):1482-8. PubMed ID: 17372279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prolactin and cancer of the breast].
    Marugo M; Giusti M; Bolognesi F; Reitano A
    Boll Soc Ital Biol Sper; 1977 Apr; 53(8):675-8. PubMed ID: 907746
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diagnosis of breast cancer metastatic to the chest (author's transl)].
    Matthiessen W; Pochhammer KF
    Med Klin; 1977 Mar; 72(10):406-9. PubMed ID: 840112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in prolactin plasma levels in relation to menopausal status in primary breast carcinoma].
    Pavić S; Pavić Z
    Med Pregl; 1995; 48(5-6):159-61. PubMed ID: 7565335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between PRL levels and steroid receptors in breast cancer.
    Marugo M; Fazzuoli L; Bernasconi D; Berta S; Giordano G
    Anticancer Res; 1988; 8(4):819-23. PubMed ID: 3178171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin and breast cancer.
    Schyve PM; Smithline F; Meltzer HY
    Psychopharmacol Bull; 1978 Jan; 14(1):17-9. PubMed ID: 625530
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dynamics of gonadotropins and prolactin in dysplasias and cancer of the breast].
    Korolev VI; Skliar SIu; Ponomarev IN
    Vrach Delo; 1988 Jan; (1):59-61. PubMed ID: 3363942
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.